A few studies have reported that B. xylanisolvens DSM 23964 increases the concentration of TFa-specific IgM serum antibodies that are involved in controlling cancer development (Schmidt et al., 2016) and exhibit no virulence in humans (Ulsemer et al., 2012). The gene discussed is CD40LG; the disease is cancer.